Skip to main content

Why Synergy (NASDAQ: SNYR) Could Hit $7 Sooner Than Expected – Beverage Rollout Ignites 2026 Growth Acceleration

NASDAQ: SNYR) Could Hit $7 Sooner Than Expected - Beverage Rollout Ignites 2026 Growth Acceleration" src="https://www.abnewswire.com/upload/2025/12/1765468643.jpg" alt="Why Synergy (NASDAQ: SNYR) Could Hit $7 Sooner Than Expected - Beverage Rollout Ignites 2026 Growth Acceleration" width="225" height="225">

Synergy CHC Corp. (NASDAQ: SNYR) is drawing renewed attention after Roth Capital Partners reaffirmed its Buy rating and issued a $7 price target, citing strong fundamentals, a growing product portfolio, and a new phase of revenue acceleration driven by the company’s expanding functional beverage business.

Along with Synergy CHC Corp. (NASDAQ: SNYR), see SmallCap Stocks to Watch Now: Black Titan (NASDAQ: BTTC), PetMed Express Inc (NASDAQ: PETS), Mawson Infrastructure (NASDAQ: MIGI) and Velo3D Inc (NASDAQ: VELO), all active in intraday trading sessions.

Roth noted that while third-quarter 2025 results came in below expectations due to temporary cash constraints, the company’s recent $4 million equity raise has fortified its balance sheet and positioned Synergy for substantial growth in 2026. Analysts highlighted that the company’s infrastructure investments and expanded retail footprint—including the rollout of FOCUSfactor® Focus + Energy into 1,600+ EG America locations—are setting the stage for a sharp sales ramp through existing distribution partners such as Costco (NASDAQ: COST), Walmart (NYSE: WMT), Amazon (NASDAQ: AMZN), CVS (NYSE: CVS), and Walgreens (NASDAQ: WBA).

Roth Capital projects revenues could rise from $35.4 million in 2025 to approximately $55 million in 2026, largely driven by the beverage division’s integration into Synergy’s well-established retail channels. Gross margins remain strong at 70%, with profitability supported by 10 consecutive positive quarters.

The firm’s $7 target is based on a 6.2x EV/EBITDA multiple of projected 2027 results, reflecting the potential for significant shareholder value as Synergy leverages its 25-year FOCUSfactor® brand legacy already established as a household name throughout the US, Canada, UK, etc. has expanded internationally into the UAE, Turkey as well as other south and central American countries.

The firm’s $7 target is based on a 6.2x EV/EBITDA multiple of projected 2027 results, underscoring the potential for substantial shareholder value as Synergy builds on its 25-year FOCUSfactor® brand legacy—already a household name across the U.S., Canada, and the U.K.—and expands internationally into the UAE, Turkey, and multiple markets throughout South and Central America.

With capital in place, new retail partnerships, and a rising consumer shift toward brain health and functional beverages, analysts believe SNYR is positioned for a breakout year in 2026 as sales momentum accelerates across all channels. See Complete Roth Capital Report.

 

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  230.28
-1.50 (-0.65%)
AAPL  278.03
-0.75 (-0.27%)
AMD  221.43
+0.01 (0.00%)
BAC  54.56
+0.48 (0.89%)
GOOG  313.70
-7.30 (-2.27%)
META  652.71
+2.58 (0.40%)
MSFT  483.47
+4.91 (1.03%)
NVDA  180.93
-2.85 (-1.55%)
ORCL  198.85
-24.16 (-10.83%)
TSLA  446.89
-4.56 (-1.01%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.